Similar to AZD6244, GSK1120212, another MEKi approved in the clinic, combined with GRB7 knockdown, induced supra-additive apoptosis in CRC cells (Supplementary Fig. S3F). This evidence concerns the gene GRB7 and colorectal carcinoma.